Notice Information
Notice Title
Cancer Vaccine Launchpad (CVLP)
Notice Description
You are invited to attend a virtual market engagement for the Cancer Vaccine Launch Pad (CVLP). Overview The CVLP is a strategic priority and collaboration between NHS England, the Department of Health and Social Care (DHSC), the Office for Life Sciences (OLS), the National Institute of Health Research (NIHR) and Genomics England (GEL), with the aim to facilitate access to personalised cancer vaccine research trials. The project was jointly announced in July 2023 with the Secretary of State and in partnership with the Prime Minister. See link (https://www.gov.uk/government/news/major-agreement-to-deliver-new-cancer-vaccine-trials#:~:text=It will work by creating,become part of standard care) Through the CVLP platform, cancer patients from across a network of up to 140 NHS cancer care providers will be asked to consent to be put forward for clinical trials. Their surplus tissue samples, obtained through standard of care pathways, will be used to assess their eligibility. The detail of any available trials will be shared with the participant and their treating clinical team to see if the patient wishes to take part, and if so, the patient will travel to the nearest trial site to access the clinical trial. The CVLP is company agnostic and is being set up in a phased approach with a small number of Trusts to test the pathway from September 2023. For the first phase, the CVLP is supporting one cancer vaccine clinical trial. It is likely that three to four additional trials will be brought into the CVLP during 2024. NHS England is looking for a supplier to provide the digital infrastructure and clinical liaison function to manage the end-to-end pathway of the CVLP for up to 2000 patients until March 2025. The supplier will be expected to have strong clinical academic leadership and experience delivering large scale, multi-centre clinical trials in patients in the UK. Estimated spend (excl. VAT): PS1,400,000 Estimated Duration: 15 months Contract duration: Proposed contract start date: 01/01/2024 Proposed contract end date: 31/03/2025 Date of event: October 17th, 2023, 9.30am - 11:00am Attendees are limited to 2 per company. To register your interest please contact england.cancervaccinelaunchpad@nhs.net and state the names and titles of those intending to attend. Thank you.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-b5fd17-7c360a0e-0f32-496b-8715-9834139cee32
- Publication Source
- Contracts Finder
- Latest Notice
- https://www.contractsfinder.service.gov.uk/Notice/d77ddb86-a42b-47bb-b845-de887d082d95
- Current Stage
- Planning
- All Stages
- Planning
Procurement Classification
- Notice Type
- Market Engagement Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Not Specified
- Procurement Method Details
- Not specified
- Tender Suitability
- SME
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
85 - Health and social work services
-
- CPV Codes
85100000 - Health services
Notice Value(s)
- Tender Value
- £1,400,000 £1M-£10M
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 10 Oct 20232 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- 16 Oct 2023Expired
- Award Date
- Not specified
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Planning
- Lots Status
- Not Specified
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS ENGLAND
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- LEEDS
- Postcode
- LS2 7UE
- Post Town
- Leeds
- Country
- England
-
- Major Region (ITL 1)
- TLE Yorkshire and The Humber
- Basic Region (ITL 2)
- TLE4 West Yorkshire
- Small Region (ITL 3)
- TLE42 Leeds
- Delivery Location
- TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England)
-
- Local Authority
- Leeds
- Electoral Ward
- Little London & Woodhouse
- Westminster Constituency
- Leeds Central and Headingley
Further Information
Notice Documents
-
https://www.contractsfinder.service.gov.uk/Notice/d77ddb86-a42b-47bb-b845-de887d082d95
10th October 2023 - Early engagement notice on Contracts Finder -
https://www.contractsfinder.service.gov.uk/Notice/ad850c7a-0c7c-49bc-b48f-684d9d0d1aa2
4th October 2023 - Early engagement notice on Contracts Finder
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-b5fd17-7c360a0e-0f32-496b-8715-9834139cee32-2023-10-10T16:53:57+01:00",
"date": "2023-10-10T16:53:57+01:00",
"ocid": "ocds-b5fd17-7c360a0e-0f32-496b-8715-9834139cee32",
"language": "en",
"initiationType": "tender",
"title": "Cancer Vaccine Launchpad (CVLP)",
"planning": {
"milestones": [
{
"id": "1",
"title": "Engagement end date",
"type": "engagement",
"dueDate": "2023-10-16T23:59:59+01:00"
}
],
"documents": [
{
"id": "1",
"documentType": "marketEngagementNotice",
"description": "Early engagement notice on Contracts Finder",
"url": "https://www.contractsfinder.service.gov.uk/Notice/ad850c7a-0c7c-49bc-b48f-684d9d0d1aa2",
"datePublished": "2023-10-04T11:44:39+01:00",
"format": "text/html",
"language": "en"
},
{
"id": "2",
"documentType": "marketEngagementNotice",
"description": "Early engagement notice on Contracts Finder",
"url": "https://www.contractsfinder.service.gov.uk/Notice/d77ddb86-a42b-47bb-b845-de887d082d95",
"datePublished": "2023-10-04T11:44:39+01:00",
"dateModified": "2023-10-10T16:53:57+01:00",
"format": "text/html",
"language": "en"
}
]
},
"tender": {
"id": "CF-1914500D0O000000rwimUAA",
"title": "Cancer Vaccine Launchpad (CVLP)",
"description": "You are invited to attend a virtual market engagement for the Cancer Vaccine Launch Pad (CVLP). Overview The CVLP is a strategic priority and collaboration between NHS England, the Department of Health and Social Care (DHSC), the Office for Life Sciences (OLS), the National Institute of Health Research (NIHR) and Genomics England (GEL), with the aim to facilitate access to personalised cancer vaccine research trials. The project was jointly announced in July 2023 with the Secretary of State and in partnership with the Prime Minister. See link (https://www.gov.uk/government/news/major-agreement-to-deliver-new-cancer-vaccine-trials#:~:text=It will work by creating,become part of standard care) Through the CVLP platform, cancer patients from across a network of up to 140 NHS cancer care providers will be asked to consent to be put forward for clinical trials. Their surplus tissue samples, obtained through standard of care pathways, will be used to assess their eligibility. The detail of any available trials will be shared with the participant and their treating clinical team to see if the patient wishes to take part, and if so, the patient will travel to the nearest trial site to access the clinical trial. The CVLP is company agnostic and is being set up in a phased approach with a small number of Trusts to test the pathway from September 2023. For the first phase, the CVLP is supporting one cancer vaccine clinical trial. It is likely that three to four additional trials will be brought into the CVLP during 2024. NHS England is looking for a supplier to provide the digital infrastructure and clinical liaison function to manage the end-to-end pathway of the CVLP for up to 2000 patients until March 2025. The supplier will be expected to have strong clinical academic leadership and experience delivering large scale, multi-centre clinical trials in patients in the UK. Estimated spend (excl. VAT): PS1,400,000 Estimated Duration: 15 months Contract duration: Proposed contract start date: 01/01/2024 Proposed contract end date: 31/03/2025 Date of event: October 17th, 2023, 9.30am - 11:00am Attendees are limited to 2 per company. To register your interest please contact england.cancervaccinelaunchpad@nhs.net and state the names and titles of those intending to attend. Thank you.",
"status": "planning",
"classification": {
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
},
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"postalCode": "LS2 7UE"
},
{
"region": "England",
"countryName": "United Kingdom"
},
{
"postalCode": "LS2 7UE"
},
{
"region": "England",
"countryName": "United Kingdom"
}
]
}
],
"value": {
"amount": 1400000,
"currency": "GBP"
},
"suitability": {
"sme": true,
"vcse": false
},
"mainProcurementCategory": "services"
},
"parties": [
{
"id": "GB-CFS-161601",
"name": "NHS England",
"identifier": {
"legalName": "NHS England"
},
"address": {
"streetAddress": "Quarry Hill",
"locality": "Leeds",
"postalCode": "LS2 7UE",
"countryName": "GB"
},
"contactPoint": {
"name": "NHSE Commercial Team",
"email": "england.cancervaccinelaunchpad@nhs.net"
},
"roles": [
"buyer"
]
}
],
"buyer": {
"id": "GB-CFS-161601",
"name": "NHS England"
}
}